Good morning. Elizabeth Cooney here again at STAT’s home in Boston, filling in for Ed Silverman who’s still in California, no doubt daydreaming about weekend plans. Some biopharma news to start the day:

After months of consideration, Louisiana officials are proceeding with plans for a “Netflix” payment model for obtaining hepatitis C treatments at an affordable price, STAT says. The state is seeking drug makers willing to supply treatments in return for subscription-based payments over five years for unlimited access to medication for anyone who is enrolled in the state Medicaid program or incarcerated in a state prison.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Ms. Cooney – thank you for this “Little” serving of the morning news. While implying that “mr ed” is ‘California Dreaming on such a Winters day’ out here in the East? (Cue the music …. )

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy